Verdict Medical Devices features the announcement of the launch of DataArt’s SkinCareAI concept app in its round-up of top stories in September.
DataArt’s Healthcare & Life Sciences Practice Launches “SkinCareAI” Prototype App for Early Melanoma Detection
London, New York, September 30, 2019 — Global technology consultancy DataArt announced today the launch of “SkinCareAI” — a prototype app that analyses skin images to detect early signs of melanoma. Using the latest advances in machine learning (ML) technology, SkinCareAI was developed by DataArt...Read More
News Medical runs the announcement of DataArt launching its 'SkinCareAI' – a prototype app that analyses skin images to detect early signs of melanoma.
New York, September 12, 2019 — DataArt, the global technology consultancy that designs, develops and supports unique software solutions, will exhibit at DPharm: Disruptive Innovations in Boston, MA, September 17-18, 2019, displaying its innovative healthcare solutions.
Daniel Piekarz, DataArt’s Head of Healthcare and Life Sciences, gives Xtalks a sneak peek at its demo applications to be presented at the Drug Information Association (DIA) Global Annual meeting in San Diego on June 24-26, 2019.
New York, June 13, 2019 — DataArt, the global technology consultancy that designs, develops and supports unique software solutions, will return to DIA 2019 on June 23-27 in San Diego, CA to exhibit and demonstrate how technology can tackle the problems in the clinical trial space.
SBC Americas posts an interview with Russel Karp, VP of Media and Entertainment at DataArt, about the innovation his team brings to the US sports betting sector.
In Deutsche Zeitschrift für Klinische Forschung, German magazine for clinical trials, Kirill Timofeev, Principal Consultant at DataArt, explains how blockchain technologies will influence clinical trials in the near future.
In PM Report, a German professional pharmaceutical magazine, Anton Dolgikh, Head of AI in the Healthcare and Life Sciences Practice at DataArt, discusses the role of natural language processing in pharmacovigilance.